Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities
Merck and Siemens signed new MoU extending their strategic partnership to accelerate digital transformation in the life science industry
No post-injection Delirium/Sedation Syndrome (PDSS) observed through 56 weeks
The goal is to deliver greater value to customers, doctors, and the broader healthcare ecosystem
Funding supports development of first-in-class pan-ROCK inhibitor ROC-101 through Phase 2a clinical testing
Encouraging early detection and breaking the silence around men’s health
Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
Element5’s Agentic AI platform will be integrated with the HCHB EHR
Dr. Brown brings extensive international experience in oncology and radiopharmaceutical development,
Subscribe To Our Newsletter & Stay Updated
